Dis-Chem Pharmacies Valuation Multiples

Dis-Chem Pharmacies is valued at $1.4B as of September 2026, a 0.6x revenue multiple. In the last FY Dis-Chem Pharmacies reported revenue of $2.6B and EBITDA of $194M.

Dis-Chem Pharmacies Overview

About Dis-Chem Pharmacies

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.


Founded

1978

HQ

South Africa

Employees

20.6K

Sectors

Financials (LTM)

Revenue: $2.8B
EBITDA: $211M

EV

$1.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dis-Chem Pharmacies Financials

Dis-Chem Pharmacies reported last 12-month revenue of $2.8B and EBITDA of $211M.

In the same LTM period, Dis-Chem Pharmacies generated $613M in gross profit, $211M in EBITDA, and $69M in net income.

Revenue (LTM)


Dis-Chem Pharmacies P&L

In the most recent fiscal year, Dis-Chem Pharmacies reported revenue of $2.6B and EBITDA of $194M.

Dis-Chem Pharmacies is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 7%, and net margin of 2%.

See analyst estimates for Dis-Chem Pharmacies
LTMLast FY202320242025202620272028
Revenue$2.8B$2.6B$2.2B$2.4B$2.6B
Gross Profit$613M$579M$503M$540M$577M
Gross Margin22%22%23%22%22%
EBITDA$211M$194M$178M$199M$197M
EBITDA Margin8%7%8%8%8%
EBIT Margin5%(4%)(3%)(3%)(4%)
Net Profit$69M$60M$61M$71M$63M
Net Margin2%2%3%3%2%
Net Debt-$239M---

Financial data powered by Morningstar, Inc.

Dis-Chem Pharmacies Stock Performance

Dis-Chem Pharmacies has current market cap of $1.4B, and enterprise value of $1.8B.

Market Cap Evolution


Dis-Chem Pharmacies' stock price is $1.61.

Dis-Chem Pharmacies share price decreased by 9.0% in the last 30 days, and by 14.9% in the last year.

Dis-Chem Pharmacies has an EPS (earnings per share) of $0.07.

See more trading valuation data for Dis-Chem Pharmacies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.8B$1.4B0.6%-9.0%-19.6%-14.9%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dis-Chem Pharmacies Valuation Multiples

Dis-Chem Pharmacies trades at 0.6x EV/Revenue multiple, and 8.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Dis-Chem Pharmacies

EV / Revenue (LTM)


Dis-Chem Pharmacies Financial Valuation Multiples

As of September 18, 2026, Dis-Chem Pharmacies has market cap of $1.4B and EV of $1.8B.

Dis-Chem Pharmacies has a P/E ratio of 19.9x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.7x0.8x0.7x0.7x
EV/EBITDA8.4x9.1x9.9x8.9x8.9x
EV/EBIT13.9x(15.9x)(29.5x)(25.9x)(16.8x)
EV/Gross Profit2.9x3.0x3.5x3.3x3.1x
P/E19.9x22.9x22.6x19.4x22.0x
EV/FCF19.2x23.6x37.5x231.6x28.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dis-Chem Pharmacies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dis-Chem Pharmacies Margins & Growth Rates

Dis-Chem Pharmacies grew revenue by 10% and EBITDA by 16% in the last fiscal year.

In the most recent fiscal year, Dis-Chem Pharmacies reported gross margin of 22%, EBITDA margin of 7%, and net margin of 2%.

See estimated margins and future growth rates for Dis-Chem Pharmacies

Dis-Chem Pharmacies Margins

Last FY202420252026202720282029
Gross Margin22%22%22%22%
EBITDA Margin7%8%8%8%
EBIT Margin(4%)(3%)(4%)3%
Net Margin2%3%2%3%
FCF Margin3%0%2%3%

Dis-Chem Pharmacies Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%8%9%9%
Gross Profit Growth10%7%7%9%
EBITDA Growth16%12%(1%)12%
EBIT Growth(224%)14%54%(192%)
Net Profit Growth26%16%(12%)16%
FCF Growth16%(84%)721%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Dis-Chem Pharmacies Operational KPIs

Dis-Chem Pharmacies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Dis-Chem Pharmacies' Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dis-Chem Pharmacies' Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dis-Chem Pharmacies
LTMLast FY202320242025202620272028
Rule of 4017%16%---
Bessemer Rule of X31%29%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-2%2%2%2%
G&A Expenses to Revenue-2%1%1%2%
Opex to Revenue-26%25%25%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dis-Chem Pharmacies Competitors

Dis-Chem Pharmacies competitors include Create SD Holdings, LBX Pharmacy, Omnicell, AiN Group, Redcare Pharmacy, GoodRx, Yixintang Pharmaceutical, Anhui Huaren Health, Aldawaa Medical Services and Medplus Health Services.

Most Dis-Chem Pharmacies public comparables operate across Pharmacies.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Create SD Holdings$3.2B$192M0.4x0.4x6.0x-
LBX Pharmacy$3.3B$345M0.5x0.5x5.1x4.9x
Omnicell$1.2B$92M1.2x1.1x15.0x8.1x
AiN Group$4.2B$310M0.5x0.5x6.4x5.8x
Redcare Pharmacy$3.4B$43M0.4x0.4x35.5x15.6x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
Yixintang Pharmaceutical$2.6B$264M0.3x0.3x3.0x6.0x
Anhui Huaren Health$818M$97M1.1x-9.6x-

This data is available for Pro users. Sign up to see all Dis-Chem Pharmacies competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dis-Chem Pharmacies

Who are competitors of Dis-Chem Pharmacies?Dis-Chem Pharmacies main competitors include Create SD Holdings, LBX Pharmacy, Omnicell, AiN Group, Redcare Pharmacy, GoodRx, Yixintang Pharmaceutical, Anhui Huaren Health, Aldawaa Medical Services, Medplus Health Services.

See public comps similar to Dis-Chem Pharmacies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial